Blood pressure medication recalled over impurity

A medication used to treat high blood pressure has been recalled by the Food and Drug Administration.

Losartan Potassium Tablets USP in 25, 50 and 100 mgs are being recalled for a higher presence of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) than the FDA allows.

The FDA said 19 lots of the medication are being recalled. See which lots are affected here.

Cancer caused by long-term exposure to high levels of NMBA is possible, the FDA said in a news release.

Losartan is used to treat “hypertension, hypertensive patients with left ventricular hypertrophy, nephropathy in Type 2 diabetic patients.”

The medication is manufactured by Vivimed in India and distributed nationwide by Heritage Pharmaceuticals, a company based in East Brunswick, New Jersey.

Recalled Losartan tablets had been distributed nationwide to wholesalers, retail pharmacies and mail order pharmacies.

Consumers should contact their doctors for guidance immediately before stopping any medication, according to the FDA.

Like WTOP on Facebook and follow @WTOP on Twitter to engage in conversation about this article and others.

© 2019 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up